GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Long-Term Deferred Tax of $426000.0 for Q1 2021, up 954.46% quarter-over-quarter from $40400.0 in Q4 2020.

GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has reported Long-Term Deferred Tax for 2 consecutive years, with $426000.0 the latest figure, recorded in Q1 2021.

In Q1 2021, Long-Term Deferred Tax changed N/A year-over-year to $426000.0; the TTM figure through Mar 2021 stood at $426000.0 (changed N/A YoY), while the FY2020 annual figure was $40400.0, changed N/A from the prior year.
Long-Term Deferred Tax rose to $426000.0 in Q1 2021 per WGS's latest filing, from $40400.0 in the prior quarter.
Across five years, Long-Term Deferred Tax topped out at $426000.0 in Q1 2021 and bottomed at $12000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	GeneDx Holdings	2.65 Bn	2.52 Bn	78.24 Mn

Download Data